版本:
中国

BRIEF-Glycomimetics' GMI-1271 receives EU orphan drug designation

May 25 Glycomimetics Inc

* Glycomimetics' GMI-1271 receives EU orphan drug designation for acute myeloid leukemia Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐